NCGI
VTAK icon

Next Century Growth Investors’s Catheter Precision VTAK Stock Holding History

Next Century Growth Investors’s Portfolio VTAK Stock Details VTAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1
Closed -$2.16M – 146
2018
Q3 		$2.16M Buy
+1
New +$4.54M 0.25% 111

Other funds holding VTAK

BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Next Century Growth Investors's VTAK Position: Q4 2018 in Review

Next Century Growth Investors sold out of Catheter Precision (VTAK) in Q4 2018, closing a stake of 1 share — an estimated $2.16M sold.

Next Century Growth Investors first reported a position in VTAK in Q3 2018 and held it in 1 quarter. The position peaked at $2.16M in Q3 2018. 10 funds tracked by Wall St. Rank hold VTAK as of Q4 2018.

  • Next Century Growth Investors reported no remaining Catheter Precision position as of Q4 2018 after selling out during the quarter.
  • Next Century Growth Investors sold 1 Catheter Precision share in Q4 2018, an estimated $2.16M.
  • Next Century Growth Investors first reported a position in Catheter Precision in Q3 2018 and held it in 1 quarter.
  • Next Century Growth Investors's Catheter Precision position peaked at $2.16M in Q3 2018.
  • 10 funds tracked by Wall St. Rank held Catheter Precision as of Q4 2018.

Based on Next Century Growth Investors's 13F filing for Q4 2018, filed 14 Feb 2019.